These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synergistic activation of the androgen receptor by bombesin and low-dose androgen. Dai J; Shen R; Sumitomo M; Stahl R; Navarro D; Gershengorn MC; Nanus DM Clin Cancer Res; 2002 Jul; 8(7):2399-405. PubMed ID: 12114445 [TBL] [Abstract][Full Text] [Related]
4. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
5. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364 [TBL] [Abstract][Full Text] [Related]
6. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
7. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503 [TBL] [Abstract][Full Text] [Related]
8. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms. Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153 [TBL] [Abstract][Full Text] [Related]
9. Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter. Read JT; Rahmani M; Boroomand S; Allahverdian S; McManus BM; Rennie PS J Biol Chem; 2007 Nov; 282(44):31954-63. PubMed ID: 17728259 [TBL] [Abstract][Full Text] [Related]
10. The PPARĪ³ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells. Moss PE; Lyles BE; Stewart LV Exp Cell Res; 2010 Dec; 316(20):3478-88. PubMed ID: 20932825 [TBL] [Abstract][Full Text] [Related]
11. Androgen-dependent regulation of Her-2/neu in prostate cancer cells. Berger R; Lin DI; Nieto M; Sicinska E; Garraway LA; Adams H; Signoretti S; Hahn WC; Loda M Cancer Res; 2006 Jun; 66(11):5723-8. PubMed ID: 16740710 [TBL] [Abstract][Full Text] [Related]
13. Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells. Xu D; Lin TH; Li S; Da J; Wen XQ; Ding J; Chang C; Yeh S Cancer Lett; 2012 Mar; 316(1):11-22. PubMed ID: 22154085 [TBL] [Abstract][Full Text] [Related]
14. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer. Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058 [TBL] [Abstract][Full Text] [Related]
15. Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha. Ko S; Shi L; Kim S; Song CS; Chatterjee B Mol Endocrinol; 2008 Feb; 22(2):273-86. PubMed ID: 17975021 [TBL] [Abstract][Full Text] [Related]
16. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. Dai JL; Burnstein KL Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268 [TBL] [Abstract][Full Text] [Related]
17. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer. van der Poel HG Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107 [TBL] [Abstract][Full Text] [Related]
18. The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer. Shamaladevi N; Araki S; Lyn DA; Ayyathurai R; Gao J; Lokeshwar VB; Navarrete H; Lokeshwar BL Oncotarget; 2016 Dec; 7(51):84201-84213. PubMed ID: 27705939 [TBL] [Abstract][Full Text] [Related]
19. CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR. Mitra R; Goodman OB Prostate; 2015 Apr; 75(5):527-38. PubMed ID: 25586052 [TBL] [Abstract][Full Text] [Related]
20. Androgen receptor W741C and T877A mutations in AIDL cells, an androgen-independent subline of prostate cancer LNCaP cells. Otsuka T; Iguchi K; Fukami K; Ishii K; Usui S; Sugimura Y; Hirano K Tumour Biol; 2011 Dec; 32(6):1097-102. PubMed ID: 21773856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]